Top

Published in:

Open Access 21-03-2022 | Long-COVID Syndrome | Review Article

When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA

Authors: J. Noll, M. Reichert, M. Dietrich, J. G. Riedel, M. Hecker, W. Padberg, M. A. Weigand, A. Hecker

Published in: Langenbeck's Archives of Surgery | Issue 4/2022

Abstract

Since the eruption of the worldwide SARS-CoV-2 pandemic in late 2019/early 2020, multiple elective surgical interventions were postponed. Through pandemic measures, elective operation capacities were reduced in favour of intensive care treatment for critically ill SARS-CoV-2 patients. Although intermittent low-incidence infection rates allowed an increase in elective surgery, surgeons have to include long-term pulmonary and extrapulmonary complications of SARS-CoV-2 infections (especially “Long Covid”) in their perioperative management considerations and risk assessment procedures. This review summarizes recent consensus statements and recommendations regarding the timepoint for surgical intervention after SARS-CoV-2 infection released by respective German societies and professional representatives including DGC/BDC (Germany Society of Surgery/Professional Association of German Surgeons e.V.) and DGAI/BDA (Germany Society of Anesthesiology and Intensive Care Medicine/Professional Association of German Anesthesiologists e.V.) within the scope of the recent literature. The current literature reveals that patients with pre- and perioperative SARS-CoV-2 infection have a dramatically deteriorated postoperative outcome. Thereby, perioperative mortality is mainly caused by pulmonary and thromboembolic complications. Notably, perioperative mortality decreases to normal values over time depending on the duration of SARS-CoV-2 infection.

Fowler AJ, Dobbs TD, Wan YI, Laloo R, Hui S, Nepogodiev D et al (2021) Resource requirements for reintroducing elective surgery during the COVID-19 pandemic: modelling study. Br J Surg 108(1):97–103. https://doi.org/10.1093/bjs/znaa012CrossRefPubMed

COVIDSurg Collaborative (2020) Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg 107(11):1440–1449. https://doi.org/10.1002/bjs.11746CrossRef

Reichert M, Sartelli M, Weigand MA, Doppstadt C, Hecker M, Reinisch-Liese A et al (2020) Impact of the SARS-CoV-2 pandemic on emergency surgery services-a multi-national survey among WSES members. World J Emerg Surg 15(1):64. https://doi.org/10.1186/s13017-020-00341-0CrossRefPubMedPubMedCentral

Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E et al (2020) Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371:m4087. https://doi.org/10.1136/bmj.m4087CrossRefPubMed

Glasbey JC, Nepogodiev D, Simoes JFF, Omar O, Li E, Venn ML et al (2020) Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study. J Clin Oncol 39(1):66–78. https://doi.org/10.1200/JCO.20.01933CrossRefPubMedPubMedCentral

Singhal R, Ludwig C, Rudge G, Gkoutos GV, Tahrani A, Mahawar K et al (2021) 30-day morbidity and mortality of bariatric surgery during the COVID-19 pandemic: a multinational cohort study of 7704 patients from 42 countries. Obes Surg 31(10):4272–4288. https://doi.org/10.1007/s11695-021-05493-9CrossRefPubMedPubMedCentral

Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Ichii H, Schubert J et al (2020) Internationally lost COVID-19 cases. J Microbiol Immunol Infect 53(3):454–458. https://doi.org/10.1016/j.jmii.2020.03.013CrossRefPubMedPubMedCentral

Lei S, Jiang F, Su W, Chen C, Chen J, Mei W et al (2020) Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine 21:100331. https://doi.org/10.1016/j.eclinm.2020.100331CrossRefPubMedPubMedCentral

Ramesh S Govindarajulu M Parise RS Neel L Shankar T Patel S et al (2021) Emerging SARS-CoV-2 variants: a review of its mutations, its implications and vaccine efficacy. Vaccines 9(10). https://doi.org/10.3390/vaccines9101195

10.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet 395(10223):497–506. https://doi.org/10.1016/s0140-6736(20)30183-5CrossRefPubMed

11.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720. https://doi.org/10.1056/NEJMoa2002032CrossRefPubMed

12.

Mallah SI, Ghorab OK, Al-Salmi S, Abdellatif OS, Tharmaratnam T, Iskandar MA et al (2021) COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob 20(1):35. https://doi.org/10.1186/s12941-021-00438-7CrossRefPubMedPubMedCentral

13.

WHO (2022) WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.

14.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271-280 e8. https://doi.org/10.1016/j.cell.2020.02.052CrossRefPubMedPubMedCentral

15.

Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454. https://doi.org/10.1038/nature02145CrossRefPubMedPubMedCentral

16.

Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H et al (2020) Structural basis of receptor recognition by SARS-CoV-2. Nature 581(7807):221–224. https://doi.org/10.1038/s41586-020-2179-yCrossRefPubMedPubMedCentral

17.

Du M, Cai G, Chen F, Christiani DC, Zhang Z, Wang M (2020) Multiomics evaluation of gastrointestinal and other clinical characteristics of COVID-19. Gastroenterol 158(8):2298-2301 e7. https://doi.org/10.1053/j.gastro.2020.03.045CrossRef

18.

Harmer D, Gilbert M, Borman R, Clark KL (2002) Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 532(2002):107–110CrossRef

19.

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS et al (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26(7):1017–1032. https://doi.org/10.1038/s41591-020-0968-3CrossRefPubMed

20.

Wu C, Zheng M, Yang Y, Gu X, Yang K, Li M et al (2020) Furin: a potential therapeutic target for COVID-19. iScience 23(10):101642CrossRef

21.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China JAMA 323(11):1061–1069. https://doi.org/10.1001/jama.2020.1585CrossRefPubMed

22.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/s0140-6736(20)30211-7CrossRefPubMedPubMedCentral

23.

RKI (2021) Epidemiologischer Steckbrief zu SARS-CoV-2 und COVID-19 https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief.html;jsessionid=78B8A0D9803B912A1FB6271495B41588.internet101?nn=13490888#doc13776792bodyText6.

24.

An C, Lim H, Kim D-W, Chang JH, Choi YJ, Kim SW (2020) Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study. Sci Rep 10(1):18716. https://doi.org/10.1038/s41598-020-75767-2CrossRefPubMedPubMedCentral

25.

Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323(13):1239–1242CrossRef

26.

Norgaard SK Vestergaard LS Nielsen J Richter L Schmid D Bustos N et al (2021) Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020. Euro Surveill 26(2). https://doi.org/10.2807/1560-7917.ES.2021.26.1.2002023

27.

Challen R, Brooks-Pollock E, Read JM, Dyson L, Tsaneva-Atanasova K, Danon L (2021) Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ 372:n579. https://doi.org/10.1136/bmj.n579CrossRefPubMed

28.

Schilling J, Lehfeld AS, Schumacher D, Ullrich A, Diercke M (2020) Krankheitsschwere der ersten COVID19-Welle in Deutschland basierend auf Meldungen gemäß Infektionsschutzgesetz. J Health Monit 5(S11):2–20

29.

WHO (2021) COVID-19 Weekly Epidemiological Update-23 March 2021 https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---23-march-2021.

30.

Wang L, He W, Yu X, Hu D, Bao M, Liu H et al (2020) Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect 80(6):639–645. https://doi.org/10.1016/j.jinf.2020.03.019CrossRefPubMedPubMedCentral

31.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW et al (2020) Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 323(20):2052–2059. https://doi.org/10.1001/jama.2020.6775CrossRefPubMedPubMedCentral

32.

Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H et al (2021) SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res 128(9):1323–1326. https://doi.org/10.1161/CIRCRESAHA.121.318902CrossRefPubMedPubMedCentral

33.

Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B et al (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436(7047):112–116. https://doi.org/10.1038/nature03712CrossRefPubMedPubMedCentral

34.

Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9–14. https://doi.org/10.1016/j.thromres.2020.04.024CrossRefPubMedPubMedCentral

35.

Marone EM, Bonalumi G, Curci R, Arzini A, Chierico S, Marazzi G et al (2020) Characteristics of venous thromboembolism in COVID-19 patients: a multicenter experience from Northern Italy. Ann Vasc Surg 68:83–87. https://doi.org/10.1016/j.avsg.2020.07.007CrossRefPubMedPubMedCentral

36.

Wichmann D, Sperhake J-P, Lutgehetmann M, Steurer S, Edler C, Heinemann A et al (2020) Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med 173(4):268–277. https://doi.org/10.7326/M20-2003CrossRefPubMed

37.

Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E et al (2020) COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC State-of-the-Art Review. J Am Coll Cardiol 75(23):2950–2973. https://doi.org/10.1016/j.jacc.2020.04.031CrossRefPubMedPubMedCentral

38.

Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E et al (2020) Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.2730CrossRefPubMedPubMedCentral

39.

Choudry FA, Hamshere SM, Rathod KS, Akhtar MM, Archbold RA, Guttmann OP et al (2020) High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction. J Am Coll Cardiol 76(10):1168–1176. https://doi.org/10.1016/j.jacc.2020.07.022CrossRefPubMedPubMedCentral

40.

Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P et al (2021) A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology 96(4):e575–e586. https://doi.org/10.1212/WNL.0000000000010979CrossRefPubMedPubMedCentral

41.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurol 77(6):683–690. https://doi.org/10.1001/jamaneurol.2020.1127CrossRefPubMed

42.

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X et al (2021) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397(10270):220–232. https://doi.org/10.1016/s0140-6736(20)32656-8CrossRefPubMedPubMedCentral

43.

Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC et al (2020) Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. MMWR 69(30):993–998PubMedPubMedCentral

44.

Yong SJ (2021) Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 53(10):737–754. https://doi.org/10.1080/23744235.2021.1924397CrossRef

45.

NICE (2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19. ISBN 978–1–4731–3943–5

46.

Koczulla AR, Ankermann T, Behrends U, Berlit P, Böing S, Brinkmann F et al (2021) S1-Leitline Post-COVID/Long-COVID. Pneumologie. 75(11):869–900. https://doi.org/10.1055/a-1551-9734CrossRefPubMed

47.

Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC et al (2021) Attributes and predictors of long COVID. Nat Med 27(4):626–631. https://doi.org/10.1038/s41591-021-01292-yCrossRefPubMedPubMedCentral

48.

Carfì A, Bernabei R, Landi F (2020) Persistent symptoms in patients after acute COVID-19. JAMA 324(6):603–605. https://doi.org/10.1001/jama.2020.12603CrossRefPubMedPubMedCentral

49.

Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P et al (2020) Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 7(7):611–627. https://doi.org/10.1016/s2215-0366(20)30203-0CrossRefPubMedPubMedCentral

50.

Lam MH-B, Wing Y-K, Yu MW-M, Leung C-M, Ma RCW, Kong APS et al (2009) Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors. Arch Intern Med 169(22):2142–2147CrossRef

51.

Ahmad MS, Shaik RA, Ahmad RK, Yusuf M, Khan M, Almutairi AB et al (2021) „LONG COVID”:an insight. Eur Rev Med Pharmacol Sci 25:5561–5577PubMed

52.

Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S et al (2021) Long COVID, a comprehensive systematic scoping review. Infection 49(6):1163–1186. https://doi.org/10.1007/s15010-021-01666-xCrossRefPubMedPubMedCentral

53.

Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AYL et al (2021) Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70(4):698–706. https://doi.org/10.1136/gutjnl-2020-323020CrossRefPubMed

54.

Proal AD, VanElzakker MB (2021) Long COVID or Post-acute Sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front Microbiol 12:698169. https://doi.org/10.3389/fmicb.2021.698169CrossRefPubMedPubMedCentral

55.

Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C (2017) Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect 96(1):1–15. https://doi.org/10.1016/j.jhin.2017.03.004CrossRefPubMed

56.

Delgado-Rodriguez M, Gomez-Ortega A, Jlorca J, Lecuona M, Dierssen T, Sillero-Arenas M et al (1999) Nosocomial infection, indices of intrinsic infection risk, and in-hospital mortality in general surgery. J Hosp 41(3):203–11. https://doi.org/10.1016/s0195-6701(99)90017-8CrossRef

57.

Encke A Haas S Kopp I Abholz H-H Bode C Bootz F et al (2015) S3-Leitlinie Prophylaxe der venösen Thromboembolie (VTE). https://www.awmf.org/uploads/tx_szleitlinien/003-001l_S3_VTE-Prophylaxe_2015-10-abgelaufen_01.pdf. Accessed 9 Mar 2022

58.

Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ (2000) Risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 160:809–815CrossRef

59.

Leonardi MJ, McGory ML, Ko CY (2007) A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol 14(2):929–936. https://doi.org/10.1245/s10434-006-9183-9CrossRefPubMed

60.

Poredos P, Poredos P, Jezovnik MK, Mavric A, Leben L, Mijovski MB et al (2021) Time course of inflammatory and procoagulant markers in the early period after total hip replacement. Clin Appl Thromb Hemost 27:1076029620985941. https://doi.org/10.1177/1076029620985941CrossRefPubMedPubMedCentral

61.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C et al (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420–422. https://doi.org/10.1016/s2213-2600(20)30076-xCrossRefPubMedPubMedCentral

62.

Battaglini D, Robba C, Rocco PRM, De Abreu MG, Pelosi P, Ball L (2019) Perioperative anaesthetic management of patients with or at risk of acute distress respiratory syndrome undergoing emergency surgery. BMC Anesthesiol 19(1):153. https://doi.org/10.1186/s12871-019-0804-9CrossRefPubMedPubMedCentral

63.

Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382:e38CrossRef

64.

Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844–847. https://doi.org/10.1111/jth.14768CrossRefPubMedPubMedCentral

65.

Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M (2020) Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis. Thromb Res 196:67–74. https://doi.org/10.1016/j.thromres.2020.08.020CrossRefPubMedPubMedCentral

66.

Giannis D, Allen SL, Tsang J, Flint S, Pinhasov T, Williams S et al (2021) Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood 137(20):2838–2847. https://doi.org/10.1182/blood.2020010529CrossRefPubMedPubMedCentral

67.

Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F et al (2020) Pulmonary embolism in patients with COVID-19. Circulation 142(2):184–186. https://doi.org/10.1161/CIRCULATIONAHA.120.047430CrossRefPubMed

68.

Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145–147. https://doi.org/10.1016/j.thromres.2020.04.013CrossRefPubMedPubMedCentral

69.

Roncon L, Zuin M, Barco S, Valerio L, Zuliani G, Zonzin P et al (2020) Incidence of acute pulmonary embolism in COVID-19 patients: systematic review and meta-analysis. Eur J Intern Med 82:29–37. https://doi.org/10.1016/j.ejim.2020.09.006CrossRefPubMedPubMedCentral

70.

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383(2):120–128. https://doi.org/10.1056/NEJMoa2015432CrossRefPubMedPubMedCentral

71.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417–1418. https://doi.org/10.1016/s0140-6736(20)30937-5CrossRefPubMedPubMedCentral

72.

Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM et al (2021) Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 18(3):194–209. https://doi.org/10.1038/s41569-020-00469-1CrossRefPubMed

73.

Goshua G, Pine AB, Meizlish ML, Chang C-H, Zhang H, Bahel P et al (2020) Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol 7(8):e575–e582. https://doi.org/10.1016/s2352-3026(20)30216-7CrossRefPubMedPubMedCentral

74.

Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V et al (2020) Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 18(7):1738–1742. https://doi.org/10.1111/jth.14850CrossRefPubMed

75.

Besnier E, Tuech J-J, Schwarz L (2020) We asked the experts: Covid-19 outbreak: is there still a place for scheduled surgery? “Reflection from pathophysiological data.” World J Surg 44(6):1695–1698. https://doi.org/10.1007/s00268-020-05501-6CrossRefPubMedPubMedCentral

76.

Blanco-Melo D, Nilsson-Payant BE, Liu W-C, Uhl S, Hoagland D, Mølller R et al (2020) Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181(5):1036-1045 e9CrossRef

77.

Ackermann M, Anders H-J, Bilyy R, Bowlin GL, Daniel C, De Lorenzo R et al (2021) Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ 28(11):3125–3139. https://doi.org/10.1038/s41418-021-00805-zCrossRefPubMedPubMedCentral

78.

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H et al (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130(5):2620–2629. https://doi.org/10.1172/JCI137244CrossRefPubMedPubMedCentral

79.

Liu J, Li S, Liu J, Liang B, Wang X, Wang H et al (2020) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55:102763. https://doi.org/10.1016/j.ebiom.2020.102763CrossRefPubMedPubMedCentral

80.

Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B et al (2020) An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med 26(10):1636–1643. https://doi.org/10.1038/s41591-020-1051-9CrossRefPubMedPubMedCentral

81.

Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y et al (2020) Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev 7(6):998–1002CrossRef

82.

Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20(6):355–362. https://doi.org/10.1038/s41577-020-0331-4CrossRefPubMedPubMedCentral

83.

Sims JT, Krishnan V, Chang C-Y, Engle SM, Casalini G, Rodgers GH et al (2021) Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19. J Allergy Clin Immunol 147(1):107–111. https://doi.org/10.1016/j.jaci.2020.08.031CrossRefPubMed

84.

Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N et al (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369:718–724CrossRef

85.

Longbottom ER, Torrance HDT, Owen HC, Fragkou PC, Hinds CJ, Pearse RM et al (2016) Features of postoperative immune suppression are reversible with interferon gamma and independent of IL-6 pathways. Ann Surg 264(2):370–377. https://doi.org/10.1097/SLA.0000000000001484CrossRefPubMed

86.

Guo Q, Zhao Y, Li J, Liu J, Yang X, Guo X et al (2021) Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19. Cell Host Microbe 29(2):222-235 e4CrossRef

87.

Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W et al (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464(7285):104–107. https://doi.org/10.1038/nature08780CrossRefPubMedPubMedCentral

88.

Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G et al (2005) Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 94(6):767–773. https://doi.org/10.1093/bja/aei143CrossRefPubMed

89.

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y et al (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan. China Clin Infect Dis 71(15):762–768. https://doi.org/10.1093/cid/ciaa248CrossRefPubMed

90.

Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L et al (2020) Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 11:827. https://doi.org/10.3389/fimmu.2020.00827CrossRefPubMedPubMedCentral

91.

Haynes L, Eaton SM, Swain SL (2002) Effect of age on naive CD4 responses: impact on effector generation and memory development. Springer Semin Immunopathol 24(1):53–60. https://doi.org/10.1007/s00281-001-0095-2CrossRefPubMed

92.

Prete A, Yan Q, Al-Tarrah K, Akturk HK, Prokop LJ, Alahdab F et al (2018) The cortisol stress response induced by surgery: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 89(5):554–567. https://doi.org/10.1111/cen.13820CrossRef

93.

Shijo H, Iwabuchi K, Hosoda S, Watanabe H, Nagaoka I, Sakakibara N (1997) Evaluation of neutrophil functions after experimental abdominal surgical trauma. Inflamm res 47:67–74CrossRef

94.

Tan TP, Arekapudi A, Metha J, Prasad A, Venkatraghavan L (2015) Neutrophil-lymphocyte ratio as predictor of mortality and morbidity in cardiovascular surgery: a systematic review. ANZ J Surg 85(6):414–419. https://doi.org/10.1111/ans.13036CrossRefPubMed

95.

Liu J Yang X Wang H Li Z Deng H Liu J et al (2021) Analysis of the long-term impact on cellular immunity in COVID-19-recovered individuals reveals a profound NKT cell impairment. mBio 12:e00085–21. https://doi.org/10.1128/mBio

96.

Siddiqi HK, Mehra MR (2020) COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 39(5):405–407. https://doi.org/10.1016/j.healun.2020.03.012CrossRefPubMedPubMedCentral

97.

Lee JS, Yum H-K, Si HJ, Han SH, Park SY, Peck KR et al (2020) Guidelines for surgery of confirmed or suspected COVID-19 patients. Infect Chemother 52(3):453–459. https://doi.org/10.3947/ic.2020.52.3.453CrossRefPubMedPubMedCentral

98.

Coccolini F, Perrone G, Chiarugi M, Di Marzo F, Ansaloni L, Scandroglio I et al (2020) Surgery in COVID-19 patients: operational directives. World J Emerg Surg 15(1):25. https://doi.org/10.1186/s13017-020-00307-2CrossRefPubMedPubMedCentral

99.

Coimbra R, Edwards S, Kurihara H, Bass GA, Balogh ZJ, Tilsed J et al (2020) European Society of Trauma and Emergency Surgery (ESTES) recommendations for trauma and emergency surgery preparation during times of COVID-19 infection. Eur J Trauma Emerg Surg 46(3):505–510. https://doi.org/10.1007/s00068-020-01364-7CrossRefPubMedPubMedCentral

100.

Abbott TEF, Fowler AJ, Dobbs TD, Gibson J, Shahid T, Dias P et al (2021) Mortality after surgery with SARS-CoV-2 infection in England: a population-wide epidemiological study. Br J Anaesth 127(2):205–214. https://doi.org/10.1016/j.bja.2021.05.018CrossRefPubMed

101.

Abate SM, Mantefardo B, Basu B (2020) Postoperative mortality among surgical patients with COVID-19: a systematic review and meta-analysis. Patient Saf Surg 14:37. https://doi.org/10.1186/s13037-020-00262-6CrossRefPubMedPubMedCentral

102.

Collaborative CovidSurg (2020) Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 396(10243):27–38. https://doi.org/10.1016/s0140-6736(20)31182-xCrossRef

103.

Kahlberg A, Mascia D, Bellosta R, Attisani L, Pegorer M, Socrate AM et al (2021) Vascular surgery during COVID-19 emergency in Hub Hospitals of Lombardy: experience on 305 patients. Eur J Vasc Endovasc Surg 61(2):306–315. https://doi.org/10.1016/j.ejvs.2020.10.025CrossRefPubMed

104.

Mi B, Chen L, Xiong Y, Xue H, Zhou W, Liu G (2020) Characteristics and early prognosis of COVID-19 infection in fracture patients. J Bone Joint Surg Am 102(9):750–758. https://doi.org/10.2106/JBJS.20.00390CrossRefPubMed

105.

COVIDSurg Collaborative (2020) Delaying surgery for patients with a previous SARS-CoV-2 infection. Br J Surg 107(12):e601–e602. https://doi.org/10.1002/bjs.12050CrossRef

106.

Doglietto F, Vezzoli M, Gheza F, Lussardi GL, Domenicucci M, Vecchiarelli L et al (2020) Factors associated with surgical mortality and complications among patients with and without coronavirus disease 2019 (COVID-19) in Italy. JAMA Surg 155(8):691–702. https://doi.org/10.1001/jamasurg.2020.2713CrossRefPubMed

107.

Catton J, Banerjea A, Gregory S, Hall C, Crooks CJ, Lewis-Lloyd CA et al (2021) Planned surgery in the COVID-19 pandemic: a prospective cohort study from Nottingham. Langenbecks Arch Surg 406(7):2469–2477. https://doi.org/10.1007/s00423-021-02207-8CrossRefPubMedPubMedCentral

108.

Jonker PKC, van der Plas WY, Steinkamp PJ, Poelstra R, Emous M, van der Meij W et al (2021) Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: a Dutch, multicenter, matched-cohort clinical study. Surgery 169(2):264–274. https://doi.org/10.1016/j.surg.2020.09.022CrossRefPubMed

109.

COVIDSurg Collaborative and GlobalSurg Collaborative (2021) Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia 76(6):748–758. https://doi.org/10.1111/anae.15458CrossRef

110.

NELA Project Team (2020) The impact of COVID-19 on emergency laparotomy-an interim report of the national emergency laparotomy audit, 23 March 2020–30 September 2020. RCoA: 1–31. https://www.nela.org.uk/downloads/COVID_analysis_08%20Mar%202021.pdf. Accessed 1 Mar 2022

111.

Becke K (2012) Anesthesia in children with a cold. Curr Opin Anaesthesiol 25(3):333–339. https://doi.org/10.1097/ACO.0b013e3283534e80CrossRefPubMed

112.

Cohen MM, Cameron CB (1991) Should you cancel the operation when a child has an upper respiratory tract infection? Anesth Analg 72:282–288CrossRef

113.

Bordet F, Allaouchiche B, Lansiaux S, Combet S, Pouyau A, Taylor P et al (2002) Risk factors for airway complications during general anaesthesia in paediatric patients. Paediatr Anaesth 12:762–769CrossRef

114.

Canet J, Gallart L, Gomar C, Paluzie G, Vallès J, Castillo J et al (2010) Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anaesthesiol V 113(6):1338–1350CrossRef

115.

Søreide K, Hallet J, Matthews JB, Schnitzbauer AA, Line PD, Lai PBS et al (2020) Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg 107(10):1250–1261. https://doi.org/10.1002/bjs.11670CrossRefPubMedPubMedCentral

116.

Thoracic Surgery Outcomes Research Network Inc (2020) COVID-19 guidance for triage of operations for thoracic malignancies: a consensus statement from thoracic surgery outcomes research network. Ann Thorac Surg 110(2):692–696. https://doi.org/10.1016/j.athoracsur.2020.03.005CrossRefPubMedCentral

117.

Berger-Richardson D, Ko G, Hong NJL (2020) Preparing for the renaissance: treating breast cancer during the COVID-19 pandemic and planning for a safe re-emergence to routine surgical care within a universal health care system. Curr Oncol 27(3):163–168. https://doi.org/10.3747/co.27.6699CrossRefPubMedPubMedCentral

118.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337. https://doi.org/10.1016/s1470-2045(20)30096-6CrossRefPubMedPubMedCentral

119.

Li Y-k, Peng S, Li L-q, Wang Q, Ping W, Zhang N et al (2020) Clinical and transmission characteristics of Covid-19 – a retrospective study of 25 cases from a single thoracic surgery department. Curr Med Sci 40(2):1–6. https://doi.org/10.1007/s11596-020-2176-2CrossRef

120.

Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China Intensive Care Med 46(5):846–848. https://doi.org/10.1007/s00134-020-05991-xCrossRefPubMed

121.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062. https://doi.org/10.1016/s0140-6736(20)30566-3CrossRefPubMedPubMedCentral

122.

Guan W-J Liang W-h Zhao Y Liang H-r Chen Z-s Li Y-m et al (2020) Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 55(5). https://doi.org/10.1183/13993003.00547-2020

123.

Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y et al (2020) Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 369:m1966. https://doi.org/10.1136/bmj.m1966CrossRefPubMedPubMedCentral

124.

Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN (2020) Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med 382(26):2582. https://doi.org/10.1056/NEJMc2021225CrossRefPubMed

125.

Guo W Li M Dong Y Zhou H Zhang Z Tian C et al (2020) Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev:e3319. https://doi.org/10.1002/dmrr.3319

126.

Feng Z, Yu Q, Yao S, Luo L, Zhou W, Mao X et al (2020) Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics. Nat Commun 11(1):4968. https://doi.org/10.1038/s41467-020-18786-xCrossRefPubMedPubMedCentral

127.

Meng Y, Wu P, Lu W, Liu K, Ma K, Huang L et al (2020) Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLoS Pathog 16(4):e1008520. https://doi.org/10.1371/journal.ppat.1008520CrossRefPubMedPubMedCentral

128.

Jiao G Jingyi O Xueping Q Yusheng J Yaqiong C Lianxiong Y et al (2020) A tool to early predict severe corona virus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis. Apr 16:ciaa443

129.

Westheim AJF, Bitorina AV, Theys J, Shiri-Sverdlov R (2021) COVID-19 infection, progression, and vaccination: focus on obesity and related metabolic disturbances. Obes Rev 22(10):e13313. https://doi.org/10.1111/obr.13313CrossRefPubMed

130.

Sjögren L, Stenberg E, Thuccani M, Martikainen J, Rylander C, Wallenius V et al (2021) Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden-A cohort study. PLoS ONE 16(10):e0257891. https://doi.org/10.1371/journal.pone.0257891CrossRefPubMedPubMedCentral

131.

DGCH/BDC und DGAI/BDA (2021) Empfehlungen von DGCH/BDC und DGAI/BDA zur Terminierung elektiver operativer Eingriffe nach Covid-19 Infektion und Impfung. https://www.dgai.de/alle-docman-dokumente/aktuelles/1696-stellungnahme-zu-operation-und-intervall-zu-covid19-impfung-oder-infektion-12-05-2021/file.html

132.

COVIDSurg Collaborative and GlobalSurg Collaborative (2021) SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Br J Surg 108(9):1056–1063. https://doi.org/10.1093/bjs/znab101CrossRef

133.

Limper U, Defosse J, Schildgen O, Wappler F (2021) Perioperative risk evaluation in patients scheduled for elective surgery in close relation to their SARS-CoV-2 vaccination. Br J Anaesth 126(6):e225–e226. https://doi.org/10.1016/j.bja.2021.03.007CrossRefPubMed

134.

Sparnon T Hadfield M (2020) Guidance on delay to elective surgery post recovery from SARS-COV 2 infection (5 August 2020) https://www.surgeons.org/-/media/Project/RACS/surgeons-org/files/news/covid19-information-hub/Perioperative-Guidance-post-COVID-infection.pdf?rev=7592ce808e8c4ac19dc2c8856bde48fa%26hash=216BF43F414EA0293F1C717E4A79E43A

135.

American Society of Anesthesiologists (ASA) and Anesthesia Patient Safety Foundation (APSF) (2021) ASA and APSFJoint Statement on Elective Surgery and Anesthesia for Patients after COVID-19 Infection (Updated March 9, 2021) https://www.asahq.org/about-asa/newsroom/news-releases/2021/03/asa-and-apsf-joint-statement-on-elective-surgery-and-anesthesia-for-patients-after-covid-19-infection-rv

136.

Hsieh M-J, Lee W-C, Cho H-Y, Wu M-F, Hu H-C, Kao K-C et al (2018) Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis. Influenza Other Respir Viruses 12(5):643–648. https://doi.org/10.1111/irv.12566CrossRefPubMedPubMedCentral

137.

Yuan M, Yin W, Tao Z, Tan W, Hu Y (2020) Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan. China PLoS One 15(3):e0230548. https://doi.org/10.1371/journal.pone.0230548CrossRefPubMed

138.

Hajifathalian K, Sharaiha RZ, Kumar S, Krisko T, Skaf D, Ang B et al (2020) Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk tool. PLoS One 15(9):e0239536CrossRef

139.

Tuty Kuswardhani RA, Henrina J, Pranata R, Lim AM, Lawrensia S, Suastika K (2020) Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis. Diabetes Metab Syndr 14(6):2103–2109. https://doi.org/10.1016/j.dsx.2020.10.022CrossRefPubMedPubMedCentral

140.

COVIDSurg Collaborative (2021) Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. Br J Surg 108(11):1274–1292. https://doi.org/10.1093/bjs/znab183CrossRef

Title: When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA
Authors: J. Noll
M. Reichert
M. Dietrich
J. G. Riedel
M. Hecker
W. Padberg
M. A. Weigand
A. Hecker
Publication date: 21-03-2022
Publisher: Springer Berlin Heidelberg
Keywords: Long-COVID Syndrome
SARS-CoV-2
COVID-19
Polymerase Chain Reaction
Published in: Langenbeck's Archives of Surgery / Issue 4/2022
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-022-02495-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2022

Outcomes of laparoscopic total gastrectomy in elderly patients: a propensity score matching analysis

Robotic redo Heller myotomy: how I do it?

Robotic versus open pancreaticoduodenectomy with vascular resection for pancreatic ductal adenocarcinoma: surgical and oncological outcomes from pilot experience

Total robotic choledochal cyst excision with Roux-en-Y hepaticojejunostomy in adults

Converted laparoscopic distal pancreatectomy: is there an impact on patient outcome and total cost?

Predictors for stone recurrence after a successful common bile duct surgical exploration for choledocholithiasis